JD Supra6h
Foreign Drug and Medical Device Manufacturers Under a Second Trump Administration: Increased Enforcement Scrutiny?
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
Le Lézard1h
Gilead's Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis
Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...
Marketplace8h
Federal layoffs spark concerns over nation’s food safety
We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...
Lawyer Kyle Diamantas Will Become New Food Center Lead at FDA
Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the Food and Drug Administration following his predecessor’s resignation earlier this week, a ...
Clearside Biomedical’s partner in China granted acceptance of arcatus NDA
Clearside Biomedical (CLSD) reported that Arctic Vision’s New Drug Application or NDA for arcatus for the treatment of uveitic macular edema ...
Lawyer Kyle Diamantas Will Become Top Food Regulator at FDA (1)
Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the US Food and Drug Administration following his predecessor’s resignation earlier this week, ...
The National Law Review20h
Health Agencies Face Terminations; Jim Jones Resigns from FDA’s Human Foods Program
Thousands of workers employed across the Department of Health and Human Services received notices that they would be ...
JD Supra7h
New Administration Outlook: Four Food Industry Insights, From RFK to FDA and SNAP to Tariffs
With the confirmation of Robert F. Kennedy Jr. as secretary of Health and Human Services, as well as Brooke Rollins as secretary of the Department ...
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...